However,
Successful bet nîmes university hospital?:
Essential
- The Nîmes University Hospital tested psilocybin, a psychedelic, in patients with alcoholism and depression. Therefore,
- After three months, more than half of the participants remained abstinent. Consequently,
- This treatment, well tolerated, opens the way to new therapeutic approaches. Similarly,
Psilocybine -based treatment, associated with psychotherapy, could help patients get out of the grip of alcohol and depression. Nevertheless, It is the bet noted by the Nîmes University Hospital. Therefore, which signs the very first French study on the subject. Moreover, And the results are promising.
Psilocybine in the service of mental health? – Successful bet nîmes university hospital?
Psilocybin is a molecule naturally present in certain hallucinogenic mushrooms. If its psychotropic effects are well known, its therapeutic potential is just beginning to be explored in France. In this pilot study called successful bet nîmes university hospital? Pad (Psilocybin in Alcohol Dependence). financed by the Institute for Research in Public Health, 30 adults recently weaned from alcohol have been recruited. All also suffered from moderate to severe depression.

.
The participants were divided into two groups: one received two high doses of psilocybin (25 mg) spaced three weeks spaced; The other received a very low dose (1 mg), playing the role of active placebo. All benefited from parallel psychotherapy, as part of a hospital program specializing in addictology.

.
The results, published in the journal Addictionare very encouraging: 55 % of patients treated with the real dose remained completely abstinent at 12 weeks, against only 11 % in the placebo group. The number of consumption days has also decreased significantly, as is the desires of alcohol. On the depression side, an improvement was observed in the two groups, without significant difference.
Towards a new generation of treatments?
The protocol turned out to be sure and achievable in a hospital environment. Only a few light side effects have been reported (headache, nausea, fatigue). “These preliminary results pave the way for new approaches to combat alcoholism, often associated with depression”explains Dr. Amandine Luquiens, addictologist responsible for the study, in a CHU press release.
For the scientific community, this double-blind controlled study could constitute a key step towards future innovative therapies. “They open the way to more -scale research to better define their place in the therapeutic arsenal”according to Dr. Luquiens. A glow of hope for patients in therapeutic dead end.
Further reading: Landes: A case of indigenous chikungunya detected in Dax – HFSS ultra-transformed food cutting can save lives, explains AHA report – This symptom under your nails can be a sign of a deadly cardiac pathology – Four new research chairs at UQTR – Here’s how to integrate 7,000 steps a day into your daily life to keep in shape.
